Home › Funds › Vanguard › Vanguard Morningstar Institutional Total Stock Market Index Fund
Fund family: Vanguard · Filed by VANGUARD INSTITUTIONAL INDEX FUNDS (CIK 862084) · SEC series S000002855
Share classes and tickers: VITNX (C000007828), VITPX (C000007829)
“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 27,077 with, 451 against, 0 abstentions (not counted as with management); 7 items carried no recommendation. Shareholder proposals: 42 FOR, 398 AGAINST, 1 abstained, by the filing’s own vote-source field.
The same two figures as Vanguard’s manager page (1,379,791 ballot items across 136 funds and accounts), counted the same way for this fund.
| 2025-2026 | This fund | Items | Vanguard | Items |
|---|---|---|---|---|
| Voted FOR the board's own proposals (directors, pay, auditor, capital, transactions, fund matters) | 98.0% | 26,354 | 94.5% | 1,082,514 |
| Backed environmental and social shareholder proposals at US companies | 0.0% | 173 | 0.9% | 6,718 |
Each ballot item this fund voted is set against the votes of the other Vanguard funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.
Voted differently from most Vanguard funds on 196 items (0.8% of the 25,818 items where a comparison was possible).
| Company | Meeting | Item | This fund | Most Vanguard funds | Mgmt | Result |
|---|---|---|---|---|---|---|
| Pacira Biosciences, Inc. | 2026-06-09 | Approval of our Amended and Restated 2011 Stock Incentive Plan. | Against | FOR — 18 of 20 Vanguard funds | Against | Failed (calculated), 43.5% support |
| Vir Biotechnology, Inc. | 2026-05-26 | To elect the following three nominees for director to hold office until the 2029 Annual Meeting of Stockholders, and until their successor is duly elected and qualified, or until their earlier death, resignation or removal: Janet Napolitano, J.D. | Withhold | FOR — 16 of 18 Vanguard funds | Against | Elected, 55.3% support |
| Harmony Biosciences Holdings, Inc. | 2026-05-14 | The election of four Class III directors to serve until our 2029 annual meeting of stockholders and until their successors are duly elected and qualified. Troy Ignelzi | For | WITHHOLD — 17 of 20 Vanguard funds | For | Elected, 70.6% support |
| Bloomin' Brands, Inc. | 2026-04-22 | Shareholder Stockholder Proposal Regarding the Issuance of "Blank-Check" Preferred Stock | Against | FOR — 14 of 16 Vanguard funds | For | Approved, 57.6% support |
| International Bancshares Corporation | 2026-05-18 | ELECTION OF DIRECTORS: D. B. Howland | For | AGAINST — 17 of 20 Vanguard funds | For | Elected, 83.4% support |
| International Bancshares Corporation | 2026-05-18 | ELECTION OF DIRECTORS: D. G. Zuniga | For | AGAINST — 17 of 20 Vanguard funds | For | Elected, 87.9% support |
| International Bancshares Corporation | 2026-05-18 | ELECTION OF DIRECTORS: L. A. Norton | For | AGAINST — 17 of 20 Vanguard funds | For | Elected, 83.5% support |
| International Bancshares Corporation | 2026-05-18 | ELECTION OF DIRECTORS: R. R. Resendez | For | AGAINST — 17 of 20 Vanguard funds | For | Elected, 87.4% support |
| Banner Corporation | 2026-05-20 | Election of twelve directors to each serve for a one-year term: Roberto R. Herencia | For | AGAINST — 16 of 19 Vanguard funds | For | Elected, 82.8% support |
| Rush Enterprises, Inc. | 2026-05-19 | Election of Directors: Dr. Kennon H. Guglielmo | For | WITHHOLD — 15 of 18 Vanguard funds | For | Passed (calculated), 78.3% support |
| Rush Enterprises, Inc. | 2026-05-19 | Election of Directors: Elaine Mendoza | For | WITHHOLD — 15 of 18 Vanguard funds | For | Passed (calculated), 67.9% support |
| Rush Enterprises, Inc. | 2026-05-19 | Election of Directors: Raymond J. Chess | For | WITHHOLD — 15 of 18 Vanguard funds | For | Passed (calculated), 77.9% support |
| Rush Enterprises, Inc. | 2026-05-19 | Election of Directors: Troy A. Clarke | For | WITHHOLD — 15 of 18 Vanguard funds | For | Passed (calculated), 78.3% support |
| Central Garden & Pet Company | 2026-02-11 | Election of Directors: Christopher T. Metz | For | WITHHOLD — 11 of 13 Vanguard funds | For | Elected, 64.5% support |
| Bumble Inc. | 2026-06-04 | Approval, on a non-binding advisory basis, of the compensation of the named executive officers as disclosed in the Proxy Statement. | For | AGAINST — 11 of 13 Vanguard funds | For | Approved, 94.5% support |
| Blue Owl Capital Inc. | 2026-06-04 | Election of Directors: Claudia Holz | For | AGAINST — 13 of 16 Vanguard funds | For | Elected, 96.9% support |
| Blue Owl Capital Inc. | 2026-06-04 | Election of Directors: Marc S. Lipschultz | For | AGAINST — 13 of 16 Vanguard funds | For | Elected, 97.5% support |
| Blue Owl Capital Inc. | 2026-06-04 | Election of Directors: Michael D. Rees | For | AGAINST — 13 of 16 Vanguard funds | For | Elected, 97.5% support |
| Fortinet, Inc. | 2026-06-12 | To elect nine directors to serve for a term of one year until the next annual meeting of stockholders or until their respective successors have been duly elected and qualified: Kenneth A. Goldman | Against | FOR — 18 of 24 Vanguard funds | Against | Passed (calculated), 84.6% support |
| Expedia Group, Inc. | 2026-06-17 | Election of Directors: Alexandr Wang | Withhold | FOR — 20 of 27 Vanguard funds | Against | Passed (calculated), 53.2% support |
| Service Corporation International | 2026-05-06 | Election of Directors: Anthony L. Coelho | For | AGAINST — 14 of 18 Vanguard funds | For | — |
| Service Corporation International | 2026-05-06 | Election of Directors: C. Park Shaper | For | AGAINST — 14 of 18 Vanguard funds | For | Passed (calculated), 82.4% support |
| Service Corporation International | 2026-05-06 | Election of Directors: Marcus A. Watts | For | AGAINST — 14 of 18 Vanguard funds | For | Failed (calculated), 43.5% support |
| Service Corporation International | 2026-05-06 | Election of Directors: Sara Martinez Tucker | For | AGAINST — 14 of 18 Vanguard funds | For | Passed (calculated), 82.6% support |
| Service Corporation International | 2026-05-06 | Election of Directors: Victor L. Lund | For | AGAINST — 14 of 18 Vanguard funds | For | Passed (calculated), 79.5% support |
| Company | Meeting | Item | This fund | Most Vanguard funds | Mgmt | Result |
|---|---|---|---|---|---|---|
| Arrowhead Pharmaceuticals, Inc. | 2026-03-19 | Advisory Vote to Approve Executive Compensation. | For | AGAINST — 18 of 24 Vanguard funds | For | — |
| AGCO Corporation | 2026-04-23 | Shareholder Stockholder proposal regarding giving stockholders an ability to call for a special stockholder meeting, if properly presented at the meeting. | For | AGAINST — 16 of 21 Vanguard funds | Against | Failed (calculated), 48.7% support |
| Douglas Emmett, Inc. | 2026-05-28 | Election of eight directors ELECTIONS OF DIRECTORS: Shirley Wang | For | WITHHOLD — 12 of 15 Vanguard funds | For | Plurality election, 30.1% support |
| The Wendy's Company | 2026-05-20 | Shareholder Stockholder proposal regarding a restriction on "blank-check" preferred stock, if properly presented at the Annual Meeting. | Against | FOR — 12 of 15 Vanguard funds | For | Approved, 51.3% support |
| Preformed Line Products Company | 2026-05-04 | To elect four directors, each for a term expiring in 2028: David C. Sunkle | Against | FOR — 10 of 12 Vanguard funds | Against | Elected, 99.9% support |
| XPEL, Inc. | 2026-06-10 | To elect as directors to the XPEL Board of Directors the six nominees named below for a term of one year: Michael A. Klonne | Withhold | FOR — 10 of 12 Vanguard funds | Against | Passed (calculated), 83.1% support |
| XPEL, Inc. | 2026-06-10 | To elect as directors to the XPEL Board of Directors the six nominees named below for a term of one year: Richard K. Crumly | Withhold | FOR — 10 of 12 Vanguard funds | Against | Passed (calculated), 70.5% support |
| XPEL, Inc. | 2026-06-10 | To elect as directors to the XPEL Board of Directors the six nominees named below for a term of one year: Stacy L. Bogart | Withhold | FOR — 10 of 12 Vanguard funds | Against | Passed (calculated), 64.6% support |
| Ardelyx, Inc. | 2026-06-16 | To approve the amendment to the Amended and Restated 2014 Equity Incentive Award Plan, or the Restated Plan, to increase the maximum number of shares of common stock that may be delivered pursuant to awards granted under the Restated Plan by 9,000,000 shares. | Against | FOR — 10 of 12 Vanguard funds | Against | Approved, 52.6% support |
| Cogent Communications Holdings, Inc. | 2026-05-01 | To approve the Third Amended and Restated 2017 Incentive Award Plan of the Company, including an increase in the number of shares available for issuance thereunder by 1.5 million shares. | For | AGAINST — 12 of 15 Vanguard funds | For | — |
| Enphase Energy, Inc. | 2026-05-13 | To elect our three nominees for director named below to hold office as members of the Board of Directors until the 2029 Annual Meeting of the Stockholders: Benjamin Kortlang | For | WITHHOLD — 13 of 17 Vanguard funds | For | Plurality election, 43.2% support |
| Enphase Energy, Inc. | 2026-05-13 | To elect our three nominees for director named below to hold office as members of the Board of Directors until the 2029 Annual Meeting of the Stockholders: Jamie Haenggi | For | WITHHOLD — 13 of 17 Vanguard funds | For | Passed (calculated), 83.9% support |
| Albemarle Corporation | 2026-05-05 | Shareholder Shareholder Proposal regarding shareholders ability to call for a special shareholder meeting. | For | AGAINST — 18 of 25 Vanguard funds | Against | Approved, 57.5% support |
| Caris Life Sciences, Inc. | 2026-06-04 | Election of Directors: Brian J. Brille | For | WITHHOLD — 9 of 11 Vanguard funds | For | Elected, 82.6% support |
| Caris Life Sciences, Inc. | 2026-06-04 | Election of Directors: Danny Phillips | For | WITHHOLD — 9 of 11 Vanguard funds | For | Elected, 81.8% support |
| Caris Life Sciences, Inc. | 2026-06-04 | Election of Directors: David Dean Halbert | For | WITHHOLD — 9 of 11 Vanguard funds | For | Elected, 82.6% support |
| Caris Life Sciences, Inc. | 2026-06-04 | Election of Directors: Jon S. Halbert | For | WITHHOLD — 9 of 11 Vanguard funds | For | Elected, 82.1% support |
| Caris Life Sciences, Inc. | 2026-06-04 | Election of Directors: Joseph E. Gilliam | For | WITHHOLD — 9 of 11 Vanguard funds | For | Elected, 82.2% support |
| Caris Life Sciences, Inc. | 2026-06-04 | Election of Directors: Peter M. Castleman | For | WITHHOLD — 9 of 11 Vanguard funds | For | Elected, 76.3% support |
| Ingles Markets, Incorporated | 2026-04-30 | Shareholder Election of Directors: Rory Held | For | WITHHOLD — 9 of 11 Vanguard funds | Against | — |
| Ingles Markets, Incorporated | 2026-04-30 | Election of Directors: Rebekah Lowe | Withhold | FOR — 9 of 11 Vanguard funds | Against | — |
| RPC, Inc. | 2026-04-28 | To elect ten Nominees for a one-year term (expiring in 2027) to the Board of Directors: Amy R. Kreisler | For | AGAINST — 9 of 11 Vanguard funds | For | Passed (calculated), 84.8% support |
| RPC, Inc. | 2026-04-28 | To elect ten Nominees for a one-year term (expiring in 2027) to the Board of Directors: John F. Wilson | For | AGAINST — 9 of 11 Vanguard funds | For | Passed (calculated), 89.1% support |
| RPC, Inc. | 2026-04-28 | To elect ten Nominees for a one-year term (expiring in 2027) to the Board of Directors: Patrick J. Gunning | For | AGAINST — 9 of 11 Vanguard funds | For | Passed (calculated), 90.3% support |
| RPC, Inc. | 2026-04-28 | To elect ten Nominees for a one-year term (expiring in 2027) to the Board of Directors: Timothy C. Rollins | For | AGAINST — 9 of 11 Vanguard funds | For | Passed (calculated), 86.4% support |
| Dream Finders Homes, Inc. | 2026-06-08 | Approval of the reincorporation of the Company to the State of Texas by conversion. | For | AGAINST — 9 of 11 Vanguard funds | For | Approved, 95.3% support |
| Dream Finders Homes, Inc. | 2026-06-08 | Election of Directors: Justin W. Udelhofen | Against | FOR — 9 of 11 Vanguard funds | Against | Elected, 96.0% support |
| Dream Finders Homes, Inc. | 2026-06-08 | Election of Directors: Leonard M. Sturm | Against | FOR — 9 of 11 Vanguard funds | Against | Elected, 96.8% support |
| Dream Finders Homes, Inc. | 2026-06-08 | Election of Directors: Megha H. Parekh | Against | FOR — 9 of 11 Vanguard funds | Against | Elected, 95.6% support |
| Enanta Pharmaceuticals, Inc. | 2026-03-11 | To approve an amendment to our 2019 Equity Incentive Plan. | For | AGAINST — 9 of 11 Vanguard funds | For | Approved, 78.4% support |
| Warner Bros. Discovery, Inc. | 2026-06-09 | ELECTION OF DIRECTORS: Joseph M. Levin | Withhold | FOR — 16 of 22 Vanguard funds | Against | Passed (calculated), 77.8% support |
| Meta Platforms, Inc. | 2026-05-27 | Election of Directors: John Elkann | For | WITHHOLD — 17 of 24 Vanguard funds | For | Elected, 82.7% support |
| Corcept Therapeutics Incorporated | 2026-05-21 | To approve an amendment to the Corcept Therapeutics Incorporated 2024 Incentive Award Plan to increase the number of shares available thereunder and clarify certain other language in the plan. | Against | FOR — 14 of 19 Vanguard funds | Against | Approved, 69.0% support |
| Avis Budget Group, Inc. | 2026-05-20 | Shareholder To vote, on an advisory basis, on a shareholder proposal to request that the Board of Directors take each step necessary so that each voting standard in our charter and bylaws that calls for a greater than simple majority vote be replaced by the applicable majority vote standard and to adjourn the a | Against | FOR — 12 of 16 Vanguard funds | For | Not approved, 10.4% support |
| Freshworks Inc. | 2026-05-28 | To approve, on an advisory basis, the compensation of our named executive officers, as disclosed in the proxy statement. | For | AGAINST — 14 of 19 Vanguard funds | For | Approved, 86.9% support |
| NovoCure Limited | 2026-06-03 | The approval of our amended and restated 2024 Omnibus Incentive Plan. | Against | FOR — 12 of 16 Vanguard funds | Against | Approved, 50.3% support |
| Alphabet Inc. | 2026-06-05 | Advisory vote to approve compensation awarded to named executive officers | For | AGAINST — 28 of 43 Vanguard funds | For | Approved, 81.1% support |
| T-Mobile US, Inc. | 2026-06-16 | Advisory Vote to Approve the Compensation Provided to the Company's Named Executive Officers for 2025. | For | AGAINST — 25 of 38 Vanguard funds | For | Approved, 73.3% support |
| Syndax Pharmaceuticals, Inc. | 2026-06-10 | To approve the Syndax Pharmaceuticals, Inc. 2026 Equity Incentive Plan. | Against | FOR — 10 of 13 Vanguard funds | Against | — |
| CenterPoint Energy, Inc. | 2026-04-16 | Approve CenterPoint Energy, Inc.'s Amended and Restated Certificate of Formation to provide for limited officer exculpation and make certain other immaterial updates. | For | AGAINST — 13 of 18 Vanguard funds | For | Approved, 60.7% support |
| CenterPoint Energy, Inc. | 2026-04-16 | Election of Directors: Christopher H. Franklin | For | AGAINST — 13 of 18 Vanguard funds | For | Elected, 85.8% support |
| CenterPoint Energy, Inc. | 2026-04-16 | Election of Directors: Dean L. Seavers | For | AGAINST — 13 of 18 Vanguard funds | For | Elected, 86.1% support |
| CenterPoint Energy, Inc. | 2026-04-16 | Election of Directors: Thaddeus J. Malik | For | AGAINST — 13 of 18 Vanguard funds | For | Elected, 86.1% support |
| CenterPoint Energy, Inc. | 2026-04-16 | Election of Directors: Theodore F. Pound | For | AGAINST — 13 of 18 Vanguard funds | For | Elected, 84.2% support |
| CenterPoint Energy, Inc. | 2026-04-16 | Election of Directors: Wendy Montoya Cloonan | For | AGAINST — 13 of 18 Vanguard funds | For | Elected, 74.9% support |
| TeraWulf Inc. | 2026-06-09 | The approval, on a non-binding, advisory basis, of the compensation of our named executive officers ("Say-on-Pay"); and | For | AGAINST — 13 of 18 Vanguard funds | For | Approved, 66.1% support |
| The E.W. Scripps Company | 2026-05-04 | Election of Directors: Kim Williams | For | WITHHOLD — 8 of 10 Vanguard funds | For | — |
| TG Therapeutics, Inc. | 2026-06-11 | An advisory vote to approve the compensation of our named executive officers. | For | AGAINST — 14 of 20 Vanguard funds | For | Failed (calculated), 39.5% support |
| Fortune Brands Innovations, Inc. | 2026-05-05 | Shareholder If properly presented, a stockholder proposal to elect each director annually | For | AGAINST — 11 of 15 Vanguard funds | — | — |
| Meta Platforms, Inc. | 2026-05-27 | Election of Directors: Dana White | For | WITHHOLD — 16 of 24 Vanguard funds | For | Elected, 91.4% support |
| Dell Technologies Inc. | 2026-06-25 | Approval of the Redomestication Proposal providing for the redomestication of Dell Technologies Inc. from Delaware to Texas by conversion as disclosed in the proxy statement | For | AGAINST — 16 of 24 Vanguard funds | For | — |
| VeriSign, Inc. | 2026-05-21 | Election of Seven Directors, Each to Serve Until the Next Annual Meeting or Until a Successor Has Been Elected and Qualified or Until the Director's Earlier Resignation or Removal: Matthew J. Desch | For | AGAINST — 15 of 22 Vanguard funds | For | Elected, 72.7% support |
| TPG Inc. | 2026-06-03 | Election of Directors: William McRaven | For | WITHHOLD — 9 of 12 Vanguard funds | For | Elected, 99.5% support |
| Tyson Foods, Inc. | 2026-02-05 | To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers. | Against | FOR — 22 of 35 Vanguard funds | Against | Passed (calculated), 82.3% support |
| CNH Industrial N.V. | 2026-05-08 | APPOINTMENT OF THE EXECUTIVE DIRECTORS AND APPOINTMENT OF THE NON-EXECUTIVE DIRECTORS: Appointment of Lorenzo Simonelli | For | AGAINST — 13 of 19 Vanguard funds | For | Passed (calculated), 85.1% support |
| Henry Schein, Inc. | 2026-05-21 | Shareholder Proposal to approve, by non-binding vote, a shareholder proposal to Govern by Majority Vote. | Against | FOR — 13 of 19 Vanguard funds | For | Approved, 57.6% support |
| The Trade Desk, Inc. | 2026-05-04 | The approval, on a non-binding, advisory basis, the compensation of our named executive officers. | For | AGAINST — 19 of 30 Vanguard funds | For | Approved, 74.7% support |
| Cogent Communications Holdings, Inc. | 2026-05-01 | To hold an advisory vote to approve named executive officer compensation. | For | AGAINST — 13 of 19 Vanguard funds | For | — |
| Welltower Inc. | 2026-05-21 | The approval, on an advisory basis, of the compensation of the named executive officers. | For | AGAINST — 21 of 34 Vanguard funds | For | Not approved, 18.9% support |
| Global Payments Inc. | 2026-04-30 | Approval, on an advisory basis, of the compensation of the company's named executive officers for 2025. | Against | FOR — 20 of 32 Vanguard funds | Against | Approved, 64.8% support |
| Wayfair Inc. | 2026-05-21 | A non-binding advisory resolution to approve executive compensation. | Against | FOR — 15 of 23 Vanguard funds | Against | Passed (calculated), 80.3% support |
| OGE Energy Corp. | 2026-05-14 | Shareholder Shareholder Proposal Regarding Simple Majority Vote. | Against | FOR — 10 of 14 Vanguard funds | For | Passed (calculated), 79.8% support |
| OPKO Health, Inc. | 2026-06-18 | To elect as directors the eleven nominees named in the attached proxy statement for a term of office expiring at the 2027 annual meeting of stockholders or until their respective successors are duly elected and qualified: Alice Lin-Tsing Yu, M.D., Ph.D. | Against | FOR — 7 of 9 Vanguard funds | Against | Elected, 90.2% support |
| OPKO Health, Inc. | 2026-06-18 | To elect as directors the eleven nominees named in the attached proxy statement for a term of office expiring at the 2027 annual meeting of stockholders or until their respective successors are duly elected and qualified: Elias A. Zerhouni, M.D. | Against | FOR — 7 of 9 Vanguard funds | Against | Elected, 90.8% support |
| OPKO Health, Inc. | 2026-06-18 | To elect as directors the eleven nominees named in the attached proxy statement for a term of office expiring at the 2027 annual meeting of stockholders or until their respective successors are duly elected and qualified: Gary J. Nabel, M.D., Ph.D. | Against | FOR — 7 of 9 Vanguard funds | Against | Elected, 90.6% support |
| OPKO Health, Inc. | 2026-06-18 | To elect as directors the eleven nominees named in the attached proxy statement for a term of office expiring at the 2027 annual meeting of stockholders or until their respective successors are duly elected and qualified: Jane H. Hsiao, Ph.D., MBA | Against | FOR — 7 of 9 Vanguard funds | Against | Elected, 91.2% support |
| OPKO Health, Inc. | 2026-06-18 | To elect as directors the eleven nominees named in the attached proxy statement for a term of office expiring at the 2027 annual meeting of stockholders or until their respective successors are duly elected and qualified: John A. Paganelli | Against | FOR — 7 of 9 Vanguard funds | Against | Elected, 85.8% support |
| OPKO Health, Inc. | 2026-06-18 | To elect as directors the eleven nominees named in the attached proxy statement for a term of office expiring at the 2027 annual meeting of stockholders or until their respective successors are duly elected and qualified: Phillip Frost, M.D. | Against | FOR — 7 of 9 Vanguard funds | Against | Elected, 91.3% support |
| OPKO Health, Inc. | 2026-06-18 | To elect as directors the eleven nominees named in the attached proxy statement for a term of office expiring at the 2027 annual meeting of stockholders or until their respective successors are duly elected and qualified: Prem A. Lachman, M.D. | Against | FOR — 7 of 9 Vanguard funds | Against | Elected, 92.4% support |
| OPKO Health, Inc. | 2026-06-18 | To elect as directors the eleven nominees named in the attached proxy statement for a term of office expiring at the 2027 annual meeting of stockholders or until their respective successors are duly elected and qualified: Richard C. Pfenniger, Jr. | Against | FOR — 7 of 9 Vanguard funds | Against | Elected, 91.5% support |
| OPKO Health, Inc. | 2026-06-18 | To elect as directors the eleven nominees named in the attached proxy statement for a term of office expiring at the 2027 annual meeting of stockholders or until their respective successors are duly elected and qualified: Roger J. Medel, M.D. | Against | FOR — 7 of 9 Vanguard funds | Against | Elected, 92.4% support |
| OPKO Health, Inc. | 2026-06-18 | To elect as directors the eleven nominees named in the attached proxy statement for a term of office expiring at the 2027 annual meeting of stockholders or until their respective successors are duly elected and qualified: Steven D. Rubin | Against | FOR — 7 of 9 Vanguard funds | Against | Elected, 88.2% support |
| Sana Biotechnology, Inc. | 2026-06-04 | To elect three Class II directors to our Board of Directors, each to serve for a three-year term expiring at the 2029 annual meeting of stockholders or until his or her respective successor is duly elected and qualified. The nominees for election are: Alise S. Reicin, M.D. | For | WITHHOLD — 7 of 9 Vanguard funds | For | — |
| Dell Technologies Inc. | 2026-06-25 | Approval, on a non-binding, advisory basis, of the compensation of Dell Technologies Inc.'s named executive officers as disclosed in the proxy statement | For | AGAINST — 18 of 29 Vanguard funds | For | Passed (calculated), 96.9% support |
| Franklin Resources, Inc. | 2026-02-03 | To elect 11 directors to the Board to hold office until the next annual meeting of stockholders or until that person's successor is elected and qualified or until his or her earlier death, resignation, retirement, disqualification or removal: Anthony J. Noto | For | AGAINST — 12 of 18 Vanguard funds | For | Elected, 85.4% support |
| Core Scientific, Inc. | 2026-05-12 | To approve, on a non-binding, advisory basis, the compensation of our named executive officers. | For | AGAINST — 12 of 18 Vanguard funds | For | Approved, 63.7% support |
| Roblox Corporation | 2026-05-28 | Advisory Vote on the Compensation of our Named Executive Officers. | For | AGAINST — 15 of 24 Vanguard funds | For | Passed (calculated), 84.2% support |
| Somnigroup International, Inc. | 2026-05-13 | ADVISORY VOTE TO APPROVE THE COMPENSATION OF NAMED EXECUTIVE OFFICERS; AND | For | AGAINST — 14 of 22 Vanguard funds | For | Passed (calculated), 58.1% support |
| Caris Life Sciences, Inc. | 2026-06-04 | Election of Directors: David Frederickson | For | WITHHOLD — 8 of 11 Vanguard funds | For | Elected, 87.0% support |
| Caris Life Sciences, Inc. | 2026-06-04 | Election of Directors: Jeffrey Vacirca, M.D. | For | WITHHOLD — 8 of 11 Vanguard funds | For | Elected, 87.1% support |
| Caris Life Sciences, Inc. | 2026-06-04 | Election of Directors: Laura I. Johansen | For | WITHHOLD — 8 of 11 Vanguard funds | For | Elected, 86.5% support |
| Caris Life Sciences, Inc. | 2026-06-04 | Election of Directors: Lloyd B. Minor, M.D. | For | WITHHOLD — 8 of 11 Vanguard funds | For | Elected, 87.1% support |
| Enanta Pharmaceuticals, Inc. | 2026-03-11 | To elect two Class I directors to serve until the 2029 Annual Meeting of Stockholders or until their respective successors are elected and qualified: Bruce L.A. Carter, Ph.D. | For | WITHHOLD — 8 of 11 Vanguard funds | For | Elected, 81.4% support |
| Veris Residential, Inc. | 2026-05-21 | To approve, by a non-binding advisory vote, the compensation that may be paid or become payable to the Company's named executive officers that is based on or otherwise relates to the Transactions, including the Mergers. | Against | FOR — 13 of 20 Vanguard funds | Against | Not approved, 44.9% support |
| GCI Liberty, Inc. | 2026-05-11 | The say-on-pay proposal, to approve, on an advisory basis, the compensation of our named executive officers. | For | AGAINST — 10 of 15 Vanguard funds | For | Approved, 83.1% support |
| Aon Plc | 2026-06-26 | Advisory resolution to approve the compensation of the Company's named executive officers. | Against | FOR — 16 of 27 Vanguard funds | Against | Not approved, 38.7% support |
| Las Vegas Sands Corp. | 2026-05-14 | An advisory (non-binding) vote to approve the compensation of the named executive officers. | For | AGAINST — 16 of 27 Vanguard funds | For | Passed (calculated), 91.3% support |
| Charter Communications, Inc. | 2026-04-21 | Approval of the amendment increasing the number of shares in the Company's 2019 Stock Incentive Plan. | For | AGAINST — 13 of 21 Vanguard funds | For | Passed (calculated), 70.8% support |
| Miami International Holdings, Inc. | 2026-06-16 | The election of the 15 director nominees: Talal Jassim Al-Bahar | Withhold | FOR — 6 of 8 Vanguard funds | Against | Passed (calculated), 75.7% support |
| Palvella Therapeutics, Inc. | 2026-06-10 | Approval of an adjournment of the Annual Meeting to the extent there are insufficient votes at the Annual Meeting to approve Proposal 5. | Against | FOR — 6 of 8 Vanguard funds | Against | Passed (calculated), 75.2% support |
| Palvella Therapeutics, Inc. | 2026-06-10 | Approval of an amendment to the 2024 Equity Incentive Plan to increase the authorized shares issuable under the 2024 Plan by 750,000 shares. | Against | FOR — 6 of 8 Vanguard funds | Against | — |
| Vera Therapeutics, Inc. | 2026-05-21 | To elect the three Class II directors named below to hold office until the Company's 2029 annual meeting of stockholders: Patrick G. Enright | For | WITHHOLD — 6 of 8 Vanguard funds | For | Elected, 92.5% support |
| Lakeland Financial Corporation | 2026-04-14 | APPROVAL, by non-binding vote, of the Company's compensation of certain executive officers. | For | AGAINST — 11 of 17 Vanguard funds | For | Passed (calculated), 75.2% support |
| Ribbon Communications Inc. | 2026-06-03 | To approve, on a non-binding, advisory basis, the compensation of Ribbon Communication Inc.'s named executive officers as disclosed in the "Compensation Discussion and Analysis" section and the accompanying compensation tables and related narratives contained in the Proxy Statement. | For | AGAINST — 6 of 8 Vanguard funds | For | Approved, 69.4% support |
| NuScale Power Corporation | 2026-05-29 | Election of Directors: Stuart Harshaw | For | WITHHOLD — 7 of 10 Vanguard funds | For | Passed (calculated), 72.3% support |
| Enovix Corporation | 2026-06-11 | To elect each of the Board of Directors' eight nominees for director named in the accompanying proxy statement, to serve as directors until the 2027 Annual Meeting of Stockholders: Thurman John Rodgers | For | WITHHOLD — 7 of 10 Vanguard funds | For | Passed (calculated), 87.0% support |
| Unisys Corporation | 2026-04-30 | Election of Directors: Matthew J. Desch | For | AGAINST — 7 of 10 Vanguard funds | For | Passed (calculated), 62.4% support |
| CuriosityStream Inc. | 2026-05-20 | To approve, on an advisory basis, the compensation paid to the Company's named executive officers as disclosed in the Proxy Statement. | For | AGAINST — 7 of 10 Vanguard funds | For | Passed (calculated), 91.2% support |
| Moderna, Inc. | 2026-05-06 | To approve, on a non-binding, advisory basis, the compensation of our named executive officers. | Against | FOR — 17 of 30 Vanguard funds | Against | Approved, 65.1% support |
| Snowflake Inc. | 2026-06-29 | Shareholder To consider and vote on, if properly presented at the meeting, a non-binding stockholder proposal requesting majority vote for director elections. | For | AGAINST — 14 of 24 Vanguard funds | Against | Approved, 64.9% support |
| Datadog, Inc. | 2026-06-15 | Shareholder The stockholder proposal, if properly presented at the Annual Meeting, requesting the adoption of a simple majority voting provision. | For | AGAINST — 12 of 20 Vanguard funds | Against | Not approved, 42.3% support |
| Twist Bioscience Corporation | 2026-02-05 | To adopt, on an advisory basis, a resolution approving the compensation of the Company's Named Executive Officers, as described in the Proxy Statement under "Executive Compensation." | For | AGAINST — 10 of 16 Vanguard funds | For | Approved, 76.4% support |
| BellRing Brands, Inc. | 2026-01-28 | Election of Directors: Robert V. Vitale | For | WITHHOLD — 10 of 16 Vanguard funds | For | Elected, 73.9% support |
| Grindr Inc. | 2026-06-02 | Election of Directors: Chad Cohen | Withhold | FOR — 5 of 7 Vanguard funds | Against | Elected, 84.4% support |
| Nabors Industries Ltd. | 2026-06-02 | Approval, on a non-binding, advisory basis, of the compensation paid by the Company to its named executive officers. | Against | FOR — 8 of 13 Vanguard funds | Against | Failed (calculated), 33.8% support |
| Krispy Kreme, Inc. | 2026-06-10 | Shareholder To vote on a stockholder proposal requesting that the Company's governing documents be amended to replace supermajority voting requirements with simple majority voting requirements; and | For | AGAINST — 5 of 7 Vanguard funds | Against | — |
| Alumis Inc. | 2026-06-30 | To elect the three Class II director nominees named below to serve until the Company's 2029 annual meeting of stockholders: Zhengbin (Bing) Yao, Ph.D. | For | WITHHOLD — 5 of 7 Vanguard funds | For | Passed (calculated), 84.1% support |
| Ginkgo Bioworks Holdings, Inc. | 2026-06-11 | Advisory vote to approve executive compensation. | Against | FOR — 9 of 15 Vanguard funds | Against | Approved, 88.4% support |
| CorMedix Inc. | 2026-06-23 | To approve an amendment to our Charter to update the approval process for amendments relating solely to the terms of one or more series of preferred stock by permitting such amendments to be approved by the holders of the applicable series, without a separate vote of common stockholders, to the exte | Against | FOR — 5 of 7 Vanguard funds | Against | Not approved, 73.9% support |
| CorMedix Inc. | 2026-06-23 | To approve the adjournment of the 2026 Annual Meeting to a later date or dates, if necessary, to permit further solicitation and voting of proxies in the event that there are insufficient votes for, or otherwise in connection with, the approval of Proposal No.s 4, 5, 6, 7 or 8. | Against | FOR — 5 of 7 Vanguard funds | Against | — |
| United States Antimony Corporation | 2026-06-12 | To elect each of the seven directors named in the Proxy Statement for a term of one year: Dr. Blaise Aguirre | For | WITHHOLD — 5 of 7 Vanguard funds | For | — |
| United States Antimony Corporation | 2026-06-12 | To elect each of the seven directors named in the Proxy Statement for a term of one year: Joseph A. Carrabba | For | WITHHOLD — 5 of 7 Vanguard funds | For | — |
| United States Antimony Corporation | 2026-06-12 | To elect each of the seven directors named in the Proxy Statement for a term of one year: Michael A. McManus | For | WITHHOLD — 5 of 7 Vanguard funds | For | — |
| Agenus Inc. | 2026-06-16 | To approve a one-time stock option exchange program under our 2019 EIP, our Amended and Restated 2009 Equity Incentive Plan, and our 2015 Inducement Equity Plan, with premium strike prices applicable to director and executive officer replacement options. | Against | FOR — 5 of 7 Vanguard funds | Against | — |
| Apartment Investment and Management Company | 2026-02-06 | Compensation Proposal. To approve, on a non-binding, advisory basis, the specified compensation that may be paid or become payable to Aimco's named executive officers in connection with the Plan of Sale and Liquidation. | Against | FOR — 11 of 19 Vanguard funds | Against | — |
| Alta Equipment Group Inc. | 2026-05-29 | To approve the First Amendment to Alta Equipment Group, Inc 2020 Omnibus Incentive Plan | Against | FOR — 5 of 7 Vanguard funds | Against | Passed (calculated), 61.6% support |
| Jefferson Capital, Inc. | 2026-06-05 | The election of David Burton, Thomas Harding and Thomas Lydon, Jr. as Class I Directors: David Burton | Withhold | FOR — 5 of 7 Vanguard funds | Against | — |
| Viant Technology Inc. | 2026-06-04 | To elect two Class II directors, to hold office until our Annual Meeting of Stockholders in 2029 and until their successors are duly elected and qualified, or until their earlier death, resignation or removal: Chris Vanderhook | For | WITHHOLD — 5 of 7 Vanguard funds | For | — |
| AMC Global Media Inc. | 2026-06-16 | Election of the following nominees as Directors: Carl E. Vogel | Withhold | FOR — 6 of 9 Vanguard funds | Against | Plurality election, 26.8% support |
| AMC Global Media Inc. | 2026-06-16 | Election of the following nominees as Directors: Debra G. Perelman | Withhold | FOR — 6 of 9 Vanguard funds | Against | Passed (calculated), 55.7% support |
| AMC Global Media Inc. | 2026-06-16 | Election of the following nominees as Directors: Matthew C. Blank | Withhold | FOR — 6 of 9 Vanguard funds | Against | Passed (calculated), 55.6% support |
| Niagen Bioscience, Inc. | 2026-06-24 | Election of Directors: Hamed Shahbazi | Withhold | FOR — 6 of 9 Vanguard funds | Against | Elected, 67.4% support |
| Miami International Holdings, Inc. | 2026-06-16 | The approval, on a non-binding advisory basis, of the compensation of our named executive officers. | For | AGAINST — 7 of 12 Vanguard funds | For | Passed (calculated), 73.9% support |
| Strata Critical Medical, Inc. | 2026-05-28 | Advisory Vote on the Compensation of our Named Executive Officers. | For | AGAINST — 5 of 8 Vanguard funds | For | Approved, 82.8% support |
| Immersion Corporation | 2026-04-06 | Advisory vote to approve the compensation of our named executive officers. | For | AGAINST — 5 of 8 Vanguard funds | For | Passed (calculated), 56.8% support |
| Definitive Healthcare Corp. | 2026-06-04 | To approve, on an advisory basis, the compensation of the Company's Named Executive Officers, as disclosed in this Proxy Statement. | For | AGAINST — 5 of 8 Vanguard funds | For | Approved, 89.6% support |
| Open Lending Corporation | 2026-06-03 | To approve, on a nonbinding advisory basis, the compensation of our named executive officers | For | AGAINST — 5 of 8 Vanguard funds | For | Approved, 67.9% support |
| TPG RE Finance Trust, Inc. | 2026-05-19 | Election of Directors: Bradley Smith | For | WITHHOLD — 4 of 6 Vanguard funds | For | Passed (calculated), 76.7% support |
| TPG RE Finance Trust, Inc. | 2026-05-19 | Election of Directors: Michael Gillmore | For | WITHHOLD — 4 of 6 Vanguard funds | For | Passed (calculated), 80.4% support |
| TPG RE Finance Trust, Inc. | 2026-05-19 | Election of Directors: Todd Schuster | For | WITHHOLD — 4 of 6 Vanguard funds | For | Passed (calculated), 95.1% support |
| TPG RE Finance Trust, Inc. | 2026-05-19 | Election of Directors: Wendy Silverstein | For | WITHHOLD — 4 of 6 Vanguard funds | For | Passed (calculated), 94.6% support |
| TPG RE Finance Trust, Inc. | 2026-05-19 | Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. | For | AGAINST — 4 of 6 Vanguard funds | For | Passed (calculated), 85.9% support |
| Dave & Buster's Entertainment, Inc. | 2026-06-18 | Election of Directors: Scott I. Ross | Against | FOR — 4 of 6 Vanguard funds | Against | Failed (calculated), 45.1% support |
| Maui Land & Pineapple Company, Inc. | 2026-05-27 | Election of Directors: To elect seven directors to serve for a one-year term to expire at the 2027 Annual Meeting of Stockholders or until their successors are elected and qualified: A. Catherine Ngo | Withhold | FOR — 4 of 6 Vanguard funds | Against | Passed (calculated), 91.9% support |
| Maui Land & Pineapple Company, Inc. | 2026-05-27 | Election of Directors: To elect seven directors to serve for a one-year term to expire at the 2027 Annual Meeting of Stockholders or until their successors are elected and qualified: Glyn Aeppel | Withhold | FOR — 4 of 6 Vanguard funds | Against | Passed (calculated), 92.5% support |
| Maui Land & Pineapple Company, Inc. | 2026-05-27 | Election of Directors: To elect seven directors to serve for a one-year term to expire at the 2027 Annual Meeting of Stockholders or until their successors are elected and qualified: Ken Ota | Withhold | FOR — 4 of 6 Vanguard funds | Against | Passed (calculated), 92.5% support |
| Faraday Future Intelligent Electric Inc. | 2026-02-13 | To approve one or more adjournments of the Special Meeting by the Company from time to time to permit further solicitation of proxies, if necessary or appropriate, if sufficient votes are not represented at the Special Meeting to approve one or more Proposals at the time of such adjournment or if ot | Against | FOR — 4 of 6 Vanguard funds | Against | Approved, 86.4% support |
| Faraday Future Intelligent Electric Inc. | 2026-02-13 | To approve the Company's Third Amended and Restated Certificate of Incorporation, as amended, to increase the number of authorized shares of the Company's Class A common stock, par value $0.0001 per share, and Class B common stock, par value $0.0001 per share, by 79,814,454, from 232,470,985 to 312, | Against | FOR — 4 of 6 Vanguard funds | Against | Approved, 75.7% support |
| BioAge Labs, Inc. | 2026-06-10 | To elect three Class II directors, to serve a three-year term through the third annual meeting of stockholders following this meeting and until a successor has been elected and qualified or until earlier resignation or removal: Patrick Enright | For | WITHHOLD — 4 of 6 Vanguard funds | For | — |
| Eledon Pharmaceuticals, Inc. | 2026-06-18 | Election of Class III Directors: James Robinson | For | WITHHOLD — 4 of 6 Vanguard funds | For | — |
| New Fortress Energy Inc. | 2026-06-17 | Conditioned upon the receipt of the requisite vote on Proposals 3a through 3g, to approve the proposed amended certificate of incorporation, in the form attached to this Proxy Statement as Annex A (the "Amended Certificate of Incorporation"), which includes the approval of all other changes in the A | For | AGAINST — 4 of 6 Vanguard funds | For | — |
| New Fortress Energy Inc. | 2026-06-17 | Election of Class I Directors: Charles M. Sledge | For | WITHHOLD — 4 of 6 Vanguard funds | For | — |
| New Fortress Energy Inc. | 2026-06-17 | Election of Class I Directors: Katherine E. Wanner | For | WITHHOLD — 4 of 6 Vanguard funds | For | — |
| New Fortress Energy Inc. | 2026-06-17 | To amend the Certificate of Incorporation to provide that holders of shares of Class A common stock of the Company will not be entitled to vote on any amendment to the Certificate of Incorporation (including any certificate of designations and any other applicable designation of capital stock) that | For | AGAINST — 4 of 6 Vanguard funds | For | — |
| Skywater Technology, Inc. | 2026-06-10 | Election of Directors: Andrew D. C. LaFrence | Withhold | FOR — 4 of 6 Vanguard funds | Against | Passed (calculated), 93.2% support |
| Skywater Technology, Inc. | 2026-06-10 | Election of Directors: Dennis J. Goetz | Withhold | FOR — 4 of 6 Vanguard funds | Against | Passed (calculated), 59.2% support |
| Skywater Technology, Inc. | 2026-06-10 | Election of Directors: Tammy J. Miller | Withhold | FOR — 4 of 6 Vanguard funds | Against | Passed (calculated), 92.9% support |
| Skywater Technology, Inc. | 2026-06-10 | Election of Directors: Timothy E. Baxter | Withhold | FOR — 4 of 6 Vanguard funds | Against | Passed (calculated), 92.4% support |
| Grindr Inc. | 2026-06-02 | To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement. | For | AGAINST — 6 of 11 Vanguard funds | For | Passed (calculated), 79.2% support |
| Quantum-Si Incorporated | 2026-05-15 | To approve, by a non-binding, advisory vote, the compensation of our named executive officers, as disclosed in this proxy statement | For | AGAINST — 5 of 9 Vanguard funds | For | — |
| Calavo Growers, Inc. | 2026-04-28 | The Merger-Related Compensation Proposal - A non-binding, advisory proposal to approve compensation that will or may become payable by Calavo to its named executive officers in connection with the transactions contemplated by the Merger Agreement. | Against | FOR — 5 of 9 Vanguard funds | Against | Not approved, 40.8% support |
| Bally's Corporation | 2026-05-19 | Approve, on a non-binding advisory basis, the compensation of the Company's named executive officers. | For | AGAINST — 4 of 7 Vanguard funds | For | Passed (calculated), 99.1% support |
| NRC Health | 2026-06-23 | NON-BINDING, ADVISORY VOTE ON THE APPROVAL OF THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS AS DISCLOSED IN THE PROXY STATEMENT. | For | AGAINST — 4 of 7 Vanguard funds | For | Approved, 85.5% support |
| JAKKS Pacific, Inc. | 2026-06-05 | To conduct an advisory vote on executive compensation. | Against | FOR — 4 of 7 Vanguard funds | Against | Not approved, 47.6% support |
| Teads Holding Co. | 2026-05-14 | Approve, on an advisory basis, the compensation of our named executive officers, described in the proxy statement. | For | AGAINST — 4 of 7 Vanguard funds | For | Passed (calculated), 88.6% support |
| Universal Logistics Holdings, Inc. | 2026-04-29 | To elect 9 directors for the coming year: Clarence W. Gooden | Withhold | FOR — 3 of 5 Vanguard funds | Against | Passed (calculated), 98.4% support |
| Universal Logistics Holdings, Inc. | 2026-04-29 | To elect 9 directors for the coming year: Frederick P. Calderone | Withhold | FOR — 3 of 5 Vanguard funds | Against | Passed (calculated), 79.7% support |
| Universal Logistics Holdings, Inc. | 2026-04-29 | To elect 9 directors for the coming year: Grant E. Belanger | Withhold | FOR — 3 of 5 Vanguard funds | Against | Passed (calculated), 92.2% support |
| Universal Logistics Holdings, Inc. | 2026-04-29 | To elect 9 directors for the coming year: H.E. "Scott" Wolfe | Withhold | FOR — 3 of 5 Vanguard funds | Against | Passed (calculated), 79.7% support |
| Universal Logistics Holdings, Inc. | 2026-04-29 | To elect 9 directors for the coming year: Marcus D. Hudson | Withhold | FOR — 3 of 5 Vanguard funds | Against | Passed (calculated), 92.8% support |
| Universal Logistics Holdings, Inc. | 2026-04-29 | To elect 9 directors for the coming year: Matthew J. Moroun | Withhold | FOR — 3 of 5 Vanguard funds | Against | — |
| Universal Logistics Holdings, Inc. | 2026-04-29 | To elect 9 directors for the coming year: Michael A. Regan | Withhold | FOR — 3 of 5 Vanguard funds | Against | Passed (calculated), 97.4% support |
| NRC Health | 2026-06-23 | APPROVAL OF AN AMENDMENT TO OUR CERTIFICATE OF INCORPORATION TO CHANGE THE VOTING REQUIREMENT FOR STOCKHOLDER ACTION BY WRITTEN CONSENT IN LIEU OF A MEETING FROM UNANIMOUS TO THE VOTING POWER THAT WOULD BE REQUIRED TO GIVE EFFECT TO THE ACTION IF IT WERE APPROVED AT A MEETING, ALONG WITH CERTAIN CLA | For | AGAINST — 3 of 5 Vanguard funds | For | Approved, 94.8% support |
| NRC Health | 2026-06-23 | APPROVAL OF AN AMENDMENT TO OUR CERTIFICATE OF INCORPORATION TO REMOVE CERTAIN SUPERMAJORITY VOTING REQUIREMENTS IN ARTICLE 6 OF OUR CERTIFICATE OF INCORPORATION, ALONG WITH CERTAIN CLARIFYING, CONFORMING, AND MINISTERIAL CHANGES. | For | AGAINST — 3 of 5 Vanguard funds | For | Approved, 95.1% support |
| Clarus Corporation | 2026-05-28 | To elect the five nominees named in the accompanying Proxy Statement to serve on the Board of Directors until the next Annual Meeting of Stockholders and until their successors are duly elected and qualified: Nicholas Sokolow | For | WITHHOLD — 3 of 5 Vanguard funds | For | Passed (calculated), 74.3% support |
| Clarus Corporation | 2026-05-28 | To elect the five nominees named in the accompanying Proxy Statement to serve on the Board of Directors until the next Annual Meeting of Stockholders and until their successors are duly elected and qualified: Roger Werner | For | WITHHOLD — 3 of 5 Vanguard funds | For | Passed (calculated), 79.9% support |
| eHealth, Inc. | 2026-06-18 | Election of Class II Directors: Beth A. Brooke | For | WITHHOLD — 3 of 5 Vanguard funds | For | Passed (calculated), 82.3% support |
| Faraday Future Intelligent Electric Inc. | 2026-05-22 | Approval of one or more adjournments of the Annual Meeting by the Company from time to time to permit further solicitation of proxies, if necessary or appropriate, if sufficient votes are not represented at the Annual Meeting to approve one or more Proposals at the time of such adjournment or if oth | Against | FOR — 3 of 5 Vanguard funds | Against | Approved, 88.4% support |
| Faraday Future Intelligent Electric Inc. | 2026-05-22 | To approve an amendment to the Company's Third Amended and Restated Certificate of Incorporation, as amended (the "Charter"), to increase (i) the number of authorized shares of the Company's Class A Common Stock, and Class B common stock, par value $0.0001 per share (the "Class B Common Stock," and, | Against | FOR — 3 of 5 Vanguard funds | Against | Approved, 80.0% support |
| BRC Inc. | 2026-05-28 | Election of Class I Directors: Lawrence "Chip" Molloy | For | AGAINST — 3 of 5 Vanguard funds | For | — |
| New Fortress Energy Inc. | 2026-06-17 | To adjourn the Annual Meeting to a later date or dates, if necessary or appropriate, to permit further solicitation and vote of proxies if there are insufficient votes to approve any of Proposals 1, 2, 3a through 3h, 4 and 5 at the time of the Annual Meeting. | For | AGAINST — 3 of 5 Vanguard funds | For | — |
Download all 196 differences (CSV)
The same votes as “with management” above, by the sector of the company voted on. 92.3% of this fund’s 27,528 such votes could be given a sector; the other 2,121 (7.7%) are at companies without one and are not in the table.
| Sector | Votes | Against management | Share |
|---|---|---|---|
| Consumer Discretionary | 5,267 | 137 | 2.6% |
| Finance | 5,007 | 50 | 1.0% |
| Industrials | 3,492 | 59 | 1.7% |
| Health Care | 3,485 | 44 | 1.3% |
| Technology | 3,060 | 89 | 2.9% |
| Real Estate | 1,522 | 5 | 0.3% |
| Utilities | 996 | 18 | 1.8% |
| Energy | 907 | 7 | 0.8% |
| Consumer Staples | 721 | 30 | 4.2% |
| Telecommunications | 383 | 10 | 2.6% |
| Basic Materials | 299 | 1 | 0.3% |
| Miscellaneous | 268 | 0 | 0.0% |
| Proposal type | Items | Against management |
|---|---|---|
| Director Elections | 19,114 | 21 |
| Say-on-Pay | 3,006 | 0 |
| Audit-related | 2,937 | 0 |
| Compensation | 994 | 11 |
| Corporate Governance | 868 | 217 |
| Capital Structure | 362 | 3 |
| Extraordinary Transactions | 263 | 4 |
| Shareholder Rights and Defenses | 97 | 22 |
| Environment or Climate | 78 | 78 |
| Other Social Issues | 64 | 64 |
Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.
| Company | Meeting | Est. position | Items | Against mgmt |
|---|---|---|---|---|
| Apple Inc. | February 24, 2026 | $5.0B | 12 | 1 |
| Microsoft Corporation | December 5, 2025 | $3.7B | 21 | 6 |
| NVIDIA Corporation | June 24, 2026 | $3.5B | 16 | 4 |
| Amazon.com, Inc. | May 20, 2026 | $2.4B | 17 | 4 |
| Alphabet Inc. | June 5, 2026 | $1.6B | 23 | 10 |
| Broadcom Inc. | April 20, 2026 | $1.5B | 10 | 0 |
| Meta Platforms, Inc. | May 27, 2026 | $1.3B | 22 | 9 |
| Eli Lilly and Company | May 4, 2026 | $1.2B | 10 | 2 |
| Meeting | Company | Proposal | Fund | Mgmt |
|---|---|---|---|---|
| February 24, 2026 | Apple Inc. | A shareholder proposal entitled "China Entanglement Audit" Shareholder proposal | Against | For |
| December 5, 2025 | Microsoft Corporation | European Security Program Censorship Risk Audit Shareholder proposal | Against | For |
| December 5, 2025 | Microsoft Corporation | Report on Risks of Censorship in Generative Artificial Intelligence Shareholder proposal | Against | For |
| June 24, 2026 | NVIDIA Corporation | Approval of a non-binding stockholder proposal requesting the replacement of supermajority voting provisions in our charter and bylaws with a simple majority voting standard. Shareholder proposal | For | Against |
| June 24, 2026 | NVIDIA Corporation | Approval of a non-binding stockholder proposal requesting a report on faith-based community resource groups. Shareholder proposal | Against | For |
| May 20, 2026 | Amazon.com, Inc. | SHAREHOLDER PROPOSAL REQUESTING A REPORT ON CHARITABLE PARTNERSHIPS Shareholder proposal | Against | For |
| May 20, 2026 | Amazon.com, Inc. | SHAREHOLDER PROPOSAL REQUESTING ADDITIONAL REPORTING ON IMPACT OF DATA CENTERS ON CLIMATE COMMITMENTS Shareholder proposal | Against | For |
| June 5, 2026 | Alphabet Inc. | Shareholder proposal regarding an enhanced disclosure on climate goals Shareholder proposal | Against | For |
| June 5, 2026 | Alphabet Inc. | Shareholder proposal regarding a report on water usage and AI development Shareholder proposal | Against | For |
| May 27, 2026 | Meta Platforms, Inc. | A shareholder proposal regarding report on Al data usage oversight. Shareholder proposal | Against | For |
| May 27, 2026 | Meta Platforms, Inc. | A shareholder proposal regarding annual vote regarding executive pay. Shareholder proposal | For | Against |
| May 4, 2026 | Eli Lilly and Company | Shareholder proposal to adopt a policy and amend the bylaws to require an independent board chair. Shareholder proposal | Against | For |
Meetings with a proxy contest or competing nominees (15 in 2025-2026), and how the fund voted the items on its ballot.
27,818 ballot items at 3,208 meetings in 2025-2026. Download all votes (CSV)
Recent votes against management’s recommendation at large companies.
In the 2025-2026 proxy season, Vanguard Morningstar Institutional Total Stock Market Index Fund (VITNX) voted at 3,208 shareholder meetings of 3,035 companies, on 27,818 ballot items in all. Where management made a recommendation, the fund followed it on 98.4% of the items and voted against it 451 times. Its most frequent area of disagreement was corporate governance (217 of its votes against management). It voted FOR 9.5% of the 440 shareholder proposals on which it cast a FOR or AGAINST vote. It voted FOR the board's own proposals more often than Vanguard's funds as a whole (98.0% against 94.5%). It voted differently from most Vanguard funds on 196 items. 15 of its meetings were contested.
Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026; the family figures are those of Vanguard’s manager page. The interactive database shows the same votes company by company, with every other fund that voted.